基于临床资料对鲍曼不动杆菌院内感染患者预后不良危险因素的回顾性分析
Retrospective Analysis of Risk Factors for Poor Prognosis in Patients with Nosocomial Acinetobacter baumannii Infection Based on Clinical Data
摘要: 目的:观察我院2024年1月~12月鲍曼不动杆菌院内感染分布情况及对应患者的临床信息,分析其发生预后不良的危险因素,探究有效预防院内感染的方法。方法:使用回顾性调查研究方法,选取我院2024年1月至12月期间鲍曼不动杆菌院内感染121例,收集对应患者的临床信息,分别采用cox回归分析和logistics回归分析发现鲍曼不动杆菌医院感染预后不良及耐碳青霉烯类鲍曼不动杆菌感染的独立危险因素。结果:多因素cox回归分析结果显示:高龄、碳青霉烯类耐药、肺部疾病、抗生素使用 > 14天、呼吸机使用是发生AB院内感染预后不良的独立危险因素;多因素logistics回归分析结果显示:ICU住院史及时长、动静脉置管及留置胃管是CRAB感染的独立危险因素(P < 0.05)。结论:高龄、部分基础疾病及有创操作、抗生素的不当使用是鲍曼不动杆菌院内感染及预后不良的独立危险因素。临床工作者应当严格指征、规范使用抗生素和有创操作,以期降低AB院内感染风险,提高患者生存率。
Abstract: Objective: To observe the distribution of nosocomial Acinetobacter baumannii infections and the clinical information of corresponding patients in our hospital from January to December 2024, analyze the risk factors for poor prognosis, and explore effective methods for preventing nosocomial infections. Methods: A retrospective survey method was used. A total of 121 cases of nosocomial Acinetobacter baumannii infections in our hospital from January to December 2024 were selected, and the clinical information of the corresponding patients was collected. Cox regression analysis and logistic regression analysis were used respectively to identify the independent risk factors for poor prognosis of Acinetobacter baumannii (AB) nosocomial infection and carbapenem-resistant Acinetobacter baumannii (CRAB) infection. Results: Multivariate Cox regression analysis showed that advanced age, carbapenem resistance, underlying lung disease, antibiotic use > 14 days, and ventilator use were independent risk factors for poor prognosis of AB nosocomial infection. Multivariate logistic regression analysis revealed that history of ICU stay, length of ICU stay, arteriovenous catheterization, and indwelling gastric tube were independent risk factors for CRAB infections (P < 0.05). Conclusion: Advanced age, certain underlying diseases, invasive procedures, and inappropriate use of antibiotics are independent risk factors for nosocomial Acinetobacter baumannii infections and poor prognosis. Clinical workers should strictly adhere to indications and standardize the use of antibiotics and invasive procedures to reduce the risk of nosocomial AB infections and improve patient survival rates.
文章引用:吴晓晗, 唐吉元昊, 王进琴, 黄颖. 基于临床资料对鲍曼不动杆菌院内感染患者预后不良危险因素的回顾性分析 [J]. 生物过程, 2025, 15(4): 245-256. https://doi.org/10.12677/bp.2025.154032

参考文献

[1] Munoz-Price, L.S. and Weinstein, R.A. (2008) Acinetobacter Infection. New England Journal of Medicine, 358, 1271-1281. [Google Scholar] [CrossRef] [PubMed]
[2] Dijkshoorn, L., Nemec, A. and Seifert, H. (2007) An Increasing Threat in Hospitals: Multidrug-Resistant Acinetobacter baumannii. Nature Reviews Microbiology, 5, 939-951. [Google Scholar] [CrossRef] [PubMed]
[3] Guo, H., Qin, J. and Xiang, J. (2016) Surveillance for and Susceptibility of Acinetobacter baumannii in a Large Hospital and Burn Center in Shanghai, China, 2007-2013. American Journal of Infection Control, 44, 1718-1719. [Google Scholar] [CrossRef] [PubMed]
[4] Vincent, J.-L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C.D., et al. (2009) International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA, 302, 2323-2329. [Google Scholar] [CrossRef] [PubMed]
[5] 章越琪, 王红萍, 徐利威, 等. 2018-2022年鲍曼不动杆菌感染情况及耐药性分析[J]. 浙江临床医学, 2024, 26(5): 735-737.
[6] Levy-Blitchtein, S., Roca, I., Plasencia-Rebata, S., Vicente-Taboada, W., Velásquez-Pomar, J., Muñoz, L., et al. (2018) Emergence and Spread of Carbapenem-Resistant Acinetobacter baumannii International Clones II and III in Lima, Peru. Emerging Microbes & Infections, 7, 119-128. [Google Scholar] [CrossRef] [PubMed]
[7] Sati, H., Carrara, E., Savoldi, A., Hansen, P., Garlasco, J., Campagnaro, E., et al. (2025) The WHO Bacterial Priority Pathogens List 2024: A Prioritisation Study to Guide Research, Development, and Public Health Strategies against Antimicrobial Resistance. The Lancet Infectious Diseases, 25, 1033-1043. [Google Scholar] [CrossRef] [PubMed]
[8] Marino, A., Augello, E., Stracquadanio, S., Bellanca, C.M., Cosentino, F., Spampinato, S., et al. (2024) Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations. International Journal of Molecular Sciences, 25, Article No. 6814. [Google Scholar] [CrossRef] [PubMed]
[9] Hussein, M.H., Schneider, E.K., Elliott, A.G., et al. (2016) From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative “Superbugs” Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators. Microbial Drug Resistance, 12, 770-777.
[10] Zhang, L.W., Feng, C.Y., Jiang, S.F., et al. (2016) Investigation and Analysis of the Prevalence Rate of Nosocomial Infection among Inpatients in a Hospital. Chinese Journal of Hospital Infection, 26, 5107-5109.
[11] 王筱, 丁丹, 张悦, 等. 2019和2023年上海市部分医院ICU环境中鲍曼不动杆菌耐药性分析[J]. 中国抗生素杂志, 2025(8): 950-955.
[12] 马晨, 韩丹, 张祎, 等. 鲍曼不动杆菌临床分布及耐药性变迁分析[J]. 中国病原生物学杂志, 2023, 18(9): 1079-1082+1087.
[13] Spellberg, B. and Bonomo, R.A. (2014) The Deadly Impact of Extreme Drug Resistance in Acinetobacter baumannii. Critical Care Medicine, 42, 1289-1291. [Google Scholar] [CrossRef] [PubMed]
[14] Wang, M.G., et al. (2024) Clinical Outcomes and Bacterial Characteristics of Carbapenem-Resistant Acinetobacter baumannii among Patients from Different Global Regions. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 78, 248-258.
[15] Karakalpakidis, D., Papadopoulos, T., Paraskeva, M., Tsitlakidou, M., Vagdatli, E., Katsifa, H., et al. (2025) When the Last Line Fails: Characterization of Colistin-Resistant Acinetobacter baumannii Reveals High Virulence and Limited Clonal Dissemination in Greek Hospitals. Pathogens, 14, Article No. 730. [Google Scholar] [CrossRef
[16] Iovleva, A., Fowler, V.G. and Doi, Y. (2024) Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections. Drugs, 85, 21-40. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, C., Wu, P., Lu, M., Ho, M. and Hsueh, P. (2023) Geographic Patterns of Carbapenem-Resistant, Multi-Drug-Resistant and Difficult-to-Treat Acinetobacter baumannii in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) Program, 2020. International Journal of Antimicrobial Agents, 61, Article ID: 106707. [Google Scholar] [CrossRef] [PubMed]
[18] Wong, D., Nielsen, T.B., Bonomo, R.A., Pantapalangkoor, P., Luna, B. and Spellberg, B. (2017) Clinical and Pathophysiological Overview of Acinetobacter Infections: A Century of Challenges. Clinical Microbiology Reviews, 30, 409-447. [Google Scholar] [CrossRef] [PubMed]
[19] Pimtimanon, N., Assawawiroonhakarn, S. and Boonsathorn, S. (2025) Carbapenem-Resistant Gram-Negative Bacteria Colonization in Immunocompromised and Critically Ill Pediatric Patients: Prevalence, Risk Factors, and Outcomes. Sage Open Pediatrics, 12. [Google Scholar] [CrossRef] [PubMed]
[20] Whiteway, C., Breine, A., Philippe, C. and Van der Henst, C. (2022) Acinetobacter baumannii. Trends in Microbiology, 30, 199-200. [Google Scholar] [CrossRef] [PubMed]
[21] Liu, C., Shih, S., Wang, N., Wu, A.Y., Sun, F., Chow, S., et al. (2016) Risk Factors of Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia. Journal of Microbiology, Immunology and Infection, 49, 934-940. [Google Scholar] [CrossRef] [PubMed]
[22] Aljindan, R., Bukharie, H., Alomar, A. and Abdalhamid, B. (2015) Prevalence of Digestive Tract Colonization of Carbapenem-Resistant Acinetobacter baumannii in Hospitals in Saudi Arabia. Journal of Medical Microbiology, 64, 400-406. [Google Scholar] [CrossRef] [PubMed]
[23] Ibrahim, M.E. (2019) Prevalence of Acinetobacter baumannii in Saudi Arabia: Risk Factors, Antimicrobial Resistance Patterns and Mechanisms of Carbapenem Resistance. Annals of Clinical Microbiology and Antimicrobials, 18, Article No. 1. [Google Scholar] [CrossRef] [PubMed]
[24] McErlean, M., Kpokiri, E., Panesar, P., Cooper, E.E., Jato, J., Orman, E., et al. (2025) Evaluation of a Hub-and-Spoke Model to Enhance Healthcare Professionals’ Practice of Antimicrobial Stewardship (AMS) Programmes in the Volta Region of Ghana. Antibiotics, 14, Article No. 672. [Google Scholar] [CrossRef] [PubMed]
[25] Yuan, X.Y., Wang, P. and Liu, J. (2025) A Novel Intelligent Approach for Infection Protection Using a Multidisciplinary Collaboration in Regional General Hospitals. Scientific Reports, 15, Article No. 22639. [Google Scholar] [CrossRef] [PubMed]